<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02790242</url>
  </required_header>
  <id_info>
    <org_study_id>AAAM2960</org_study_id>
    <nct_id>NCT02790242</nct_id>
  </id_info>
  <brief_title>Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy</brief_title>
  <acronym>RESCUE</acronym>
  <official_title>Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hiroo Takayama</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to gather information on patients who have heart failure and are
      eligible for one of the following two procedures: 1) mechanical support, i.e. ventricular
      assist device (VAD) or 2) heart transplant. the study seeks to determine which patient
      populations benefit from heart transplant or ventricular assist device. This will allow to
      offer the state-of-the-art care to the patients in heart failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiogenic shock (CS) develops in the end stage of various etiologies of heart failure and
      continues to hold high mortality; ranging from 50 to 80%. Expert consensus recommends use of
      more powerful mechanical circulatory support device (MCSD) in this patient population;
      however, scientific evidence has been anecdotal relying on mostly single-center small case
      series and, more fundamentally, because there is no unified definition to grade the severity
      of the highly heterogeneous condition CS. Well-designed studies are warranted to precisely
      characterize the various &quot;phenotypes&quot; of CS as well as the role of MCSD in this condition
      with still excessive mortality.

      This multicenter registry will be the first multicenter large-scale registry focused on
      mechanical circulatory support (MCS) therapy for CS. The fundamental goal of RESCUE is to
      advance the understanding and application of MCSD in order to improve the persistently dismal
      survival of patients with CS with the following intents:

        1. Elucidate current indication and outcomes of MCSD use in CS.

        2. Redefine CS with better description of this disease entity, which will allow better
           prediction of outcomes, selection of treatment strategy, and comparison and design of
           studies.

        3. Facilitate the refinement of patient selection to maximize outcomes with current and new
           device options.

        4. Improve and expedite new device clinical trials by providing historical control data.

        5. Develop consensus &quot;best practice&quot; guidelines to improve clinical management by reducing
           short and long-term complications of MCSD therapy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>1-year survival post mechanical circulatory assist device implant</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>survival to discharge post mechanical circulatory assist device implant</measure>
    <time_frame>until the enrolled patient is discharged. Expected to occur within 90 days of enrollment.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30-day survival post mechanical circulatory assist device implant</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of adverse events during mechanical circulatory assist device support</measure>
    <time_frame>up to 30-days of weaning from the device.</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">200000</enrollment>
  <condition>Heart Failure</condition>
  <condition>Cardiogenic Shock</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Potential subjects include all adult patients who underwent evaluation for MCS for
        cardiogenic shock. Each adult patient who receives an MCSD at an institution will be
        screened according to the inclusion and exclusion criteria listed below.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients who receive any MCSD including Veno-Arterial Extracorporeal Membrane
             Oxygenation (VA ECMO), surgical VAD, and percutaneous VAD, used to treat CS on or
             after 9/30/10. Intraaortic balloon pumping (IABP) is not considered an MCSD in this
             Registry.

          -  Adult patients who have signed informed consent. For patients who are too ill to give
             informed consent the health care proxy of the patient or next of kin will be
             approached for the informed consent.

        Exclusion Criteria:

          -  patients younger than 18 years of age.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hiroo Takayama, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hiroo Takayama, MD, PhD</last_name>
    <phone>212-305-0828</phone>
    <email>ht2225@cumc.columbia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lyn Goldsmith, RN, BSN</last_name>
    <phone>212-342-0261</phone>
    <email>lg2240@cumc.columbia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Colarodo</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Lucas, MPS, CCP</last_name>
      <phone>720-848-9745</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Minneapolis Heart Institute</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Sun, MD</last_name>
      <phone>612-863-3900</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>St Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Akinobu Itoh, MD, PhD</last_name>
      <phone>314-362-8008</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Newark Beth Israel Medical center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margarita Camacho, MD</last_name>
      <phone>973-926-7904</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hiroo Takayam, MD, PhD</last_name>
      <phone>212-305-0828</phone>
      <email>HT2225@cumc.columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Lyn Goldsmith, RN, BSN</last_name>
      <phone>212-342-0261</phone>
      <email>LG2240@cumc.columbia.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Hiroo Takayama, MD, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Westchester Medical Center</name>
      <address>
        <city>Valhalla</city>
        <state>New York</state>
        <zip>10595</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Masashi Kai, MD</last_name>
      <phone>914-493-8793</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mani A. Daneshmand, MD</last_name>
      <phone>919-681-5925</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999 Aug 26;341(9):625-34.</citation>
    <PMID>10460813</PMID>
  </reference>
  <reference>
    <citation>Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, BÃ¶hm M, Ebelt H, Schneider S, Schuler G, Werdan K; IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012 Oct 4;367(14):1287-96. doi: 10.1056/NEJMoa1208410. Epub 2012 Aug 26.</citation>
    <PMID>22920912</PMID>
  </reference>
  <reference>
    <citation>Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Baldwin JT, Young JB. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013 Feb;32(2):141-56. doi: 10.1016/j.healun.2012.12.004. Erratum in: J Heart Lung Transplant. 2015 Oct;34(10):1356. Timothy Baldwin, J [corrected to Baldwin, J T].</citation>
    <PMID>23352390</PMID>
  </reference>
  <reference>
    <citation>Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson L, Miller M, Young JB. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg. 2012 Sep;144(3):584-603; discussion 597-8. doi: 10.1016/j.jtcvs.2012.05.044. Epub 2012 Jul 15.</citation>
    <PMID>22795459</PMID>
  </reference>
  <reference>
    <citation>O'Connor CM, Rogers JG. Evidence for overturning the guidelines in cardiogenic shock. N Engl J Med. 2012 Oct 4;367(14):1349-50. doi: 10.1056/NEJMe1209601. Epub 2012 Aug 26.</citation>
    <PMID>22920913</PMID>
  </reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2016</study_first_submitted>
  <study_first_submitted_qc>June 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2016</study_first_posted>
  <last_update_submitted>June 2, 2016</last_update_submitted>
  <last_update_submitted_qc>June 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Hiroo Takayama</investigator_full_name>
    <investigator_title>Assistant Professor of Surgery at CUMC</investigator_title>
  </responsible_party>
  <keyword>Mechanical Circulatory Support Device (MCSD)</keyword>
  <keyword>ventricular Assist Device (VAD)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Cardiogenic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

